These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 38801579)

  • 1. Poxviridae Pneumonia.
    Nucera F; Bonina L; Cipolla A; Pirina P; Hansbro PM; Adcock IM; Caramori G
    Adv Exp Med Biol; 2024; 1451():183-204. PubMed ID: 38801579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and Vaccination for Smallpox and Monkeypox.
    Saalbach KP
    Adv Exp Med Biol; 2024; 1451():301-316. PubMed ID: 38801586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections.
    De Clercq E
    Clin Microbiol Rev; 2001 Apr; 14(2):382-97. PubMed ID: 11292644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic strategies for human poxvirus infections: Monkeypox (mpox), smallpox, molluscipox, and orf.
    De Clercq E; Jiang Y; Li G
    Travel Med Infect Dis; 2023; 52():102528. PubMed ID: 36539022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [We should be prepared to smallpox re-emergence.].
    Shchelkunov SN; Shchelkunova GA
    Vopr Virusol; 2019; 64(5):206-214. PubMed ID: 32167685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poxvirus Vaccines: Past, Present, and Future.
    Jhancy M
    Adv Exp Med Biol; 2024; 1451():273-287. PubMed ID: 38801584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cidofovir in the treatment of poxvirus infections.
    De Clercq E
    Antiviral Res; 2002 Jul; 55(1):1-13. PubMed ID: 12076747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses.
    Smee DF; Sidwell RW; Kefauver D; Bray M; Huggins JW
    Antimicrob Agents Chemother; 2002 May; 46(5):1329-35. PubMed ID: 11959564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Virology of Orthopoxviruses with Special Reference to Monkeypox Virus.
    Rohaim MA; Naggar RFE; Atasoy MO; Munir M
    Adv Exp Med Biol; 2024; 1451():111-124. PubMed ID: 38801574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smallpox vaccines: targets of protective immunity.
    Moss B
    Immunol Rev; 2011 Jan; 239(1):8-26. PubMed ID: 21198662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses.
    Belyakov IM; Earl P; Dzutsev A; Kuznetsov VA; Lemon M; Wyatt LS; Snyder JT; Ahlers JD; Franchini G; Moss B; Berzofsky JA
    Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9458-63. PubMed ID: 12869693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications.
    Russo AT; Grosenbach DW; Chinsangaram J; Honeychurch KM; Long PG; Lovejoy C; Maiti B; Meara I; Hruby DE
    Expert Rev Anti Infect Ther; 2021 Mar; 19(3):331-344. PubMed ID: 32882158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.
    Meseda CA; Weir JP
    Future Microbiol; 2010 Sep; 5(9):1367-82. PubMed ID: 20860482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of tecovirimat (ST-246) in nonhuman primates infected with variola virus (Smallpox).
    Mucker EM; Goff AJ; Shamblin JD; Grosenbach DW; Damon IK; Mehal JM; Holman RC; Carroll D; Gallardo N; Olson VA; Clemmons CJ; Hudson P; Hruby DE
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6246-53. PubMed ID: 24100494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of delayed brincidofovir treatment against a lethal rabbitpox virus challenge in New Zealand White rabbits.
    Grossi IM; Foster SA; Gainey MR; Krile RT; Dunn JA; Brundage T; Khouri JM
    Antiviral Res; 2017 Jul; 143():278-286. PubMed ID: 28392420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Countermeasures to the bioterrorist threat of smallpox.
    Jahrling PB; Fritz EA; Hensley LE
    Curr Mol Med; 2005 Dec; 5(8):817-26. PubMed ID: 16375715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development.
    Lorenzo MM; Nogales A; Chiem K; Blasco R; Martínez-Sobrido L
    Microbiol Spectr; 2022 Jun; 10(3):e0027222. PubMed ID: 35583360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of camels to intradermal inoculation with smallpox and camelpox viruses.
    Baxby D; Hessami M; Ghaboosi B; Ramyar H
    Infect Immun; 1975 Apr; 11(4):617-21. PubMed ID: 164403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model.
    Hutson CL; Kondas AV; Mauldin MR; Doty JB; Grossi IM; Morgan CN; Ostergaard SD; Hughes CM; Nakazawa Y; Kling C; Martin BE; Ellison JA; Carroll DS; Gallardo-Romero NF; Olson VA
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33536322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human FAM111A inhibits vaccinia virus replication by degrading viral protein I3 and is antagonized by poxvirus host range factor SPI-1.
    Zhu J; Gao X; Li Y; Zhang Z; Xie S; Ren S; Li Y; Li H; Niu K; Fu S; Deng Y; Li Y; Moss B; Wu W; Peng C
    Proc Natl Acad Sci U S A; 2023 Aug; 120(35):e2304242120. PubMed ID: 37607234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.